Medibank Pvt Ltd
MPL: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$6.70 | Qywvpzy | Yfrgdqcc |
Medibank: Policyholder Growth Still Expected, Booming Students and Workers a Nice Tailwind
Medibank’s third-quarter update and largely unchanged fiscal 2023 outlook leave Australia’s largest private health insurer on track to meet our forecasts and our AUD 3.30 fair value estimate stands.